Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Eli Lilly
LLY
|
$534M |
| 2 |
Amazon
AMZN
|
$432M |
| 3 |
Abbott
ABT
|
$420M |
| 4 |
Adobe
ADBE
|
$365M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$277M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
$472M |
| 2 |
Bank of America
BAC
|
$426M |
| 3 |
TE Connectivity
TEL
|
$399M |
| 4 |
Atlassian
TEAM
|
$364M |
| 5 |
Goldman Sachs
GS
|
$348M |
Sector Composition
| 1 | Technology | 32.59% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.8% |
| 4 | Industrials | 9.76% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Boston Scientific
BSX
$156B
| $1.12B | 0.67% |
19,450,617
-1,107,041
| -5% | -$64M |
|
27
Danaher
DHR
$147B
| $1.08B | 0.64% |
4,647,414
-263,646
| -5% | -$61M |
|
28
Visa
V
$683B
| $1.05B | 0.63% |
4,033,641
-87,295
| -2% | -$22.7M |
|
29
Accenture
ACN
$162B
| $1.02B | 0.61% |
2,898,991
-53,911
| -2% | -$18.9M |
|
30
ON Semiconductor
ON
$20.3B
| $997M | 0.59% |
11,940,224
-533,652
| -4% | -$44.6M |
|
|
31
Vertex Pharmaceuticals
VRTX
$100B
| $952M | 0.57% |
2,339,979
+681,156
| +41% | +$277M |
|
32
Howmet Aerospace
HWM
$70.2B
| $926M | 0.55% |
17,110,693
-1,716,589
| -9% | -$92.9M |
|
33
SS&C Technologies
SSNC
$21.7B
| $914M | 0.55% |
14,952,469
+66,161
| +0.4% | +$4.04M |
|
34
Liberty Media Series C
FWONK
$25B
| $902M | 0.54% |
14,295,723
+718,197
| +5% | +$45.3M |
|
35
CoStar Group
CSGP
$37.9B
| $877M | 0.52% |
10,034,463
+1,050,656
| +12% | +$91.8M |
|
36
Procter & Gamble
PG
$368B
| $869M | 0.52% |
5,929,273
-1,761,619
| -23% | -$258M |
|
37
Flex
FLEX
$20.1B
| $856M | 0.51% |
28,096,966
+1,276,726
| +5% | +$38.9M |
|
38
GoDaddy
GDDY
$20.5B
| $843M | 0.5% |
7,939,918
+35,136
| +0.4% | +$3.73M |
|
39
McDonald's
MCD
$224B
| $835M | 0.5% |
2,814,736
+67,934
| +2% | +$20.1M |
|
40
WEX
WEX
$5.87B
| $796M | 0.47% |
4,090,463
+19,207
| +0.5% | +$3.74M |
|
41
American Express
AXP
$230B
| $793M | 0.47% |
4,231,599
-74,386
| -2% | -$13.9M |
|
42
Linde
LIN
$222B
| $793M | 0.47% |
1,929,992
+14,956
| +0.8% | +$6.14M |
|
43
ASML
ASML
$285B
| $776M | 0.46% |
1,025,853
+58,090
| +6% | +$44M |
|
44
Marvell Technology
MRVL
$55.7B
| $717M | 0.43% |
11,886,598
+936,735
| +9% | +$56.5M |
|
45
Thermo Fisher Scientific
TMO
$186B
| $715M | 0.43% |
1,347,636
-165,204
| -11% | -$87.7M |
|
46
Nike
NKE
$110B
| $691M | 0.41% |
6,367,025
+3,039
| +0% | +$330K |
|
47
Broadridge
BR
$29.9B
| $686M | 0.41% |
3,335,064
+13,520
| +0.4% | +$2.78M |
|
48
Wabtec
WAB
$33.1B
| $684M | 0.41% |
5,390,674
-25,105
| -0.5% | -$3.19M |
|
49
Teledyne Technologies
TDY
$25.2B
| $681M | 0.41% |
1,526,282
+71,836
| +5% | +$32.1M |
|
50
argenx
ARGX
$43.6B
| $676M | 0.4% |
1,776,759
+305,621
| +21% | +$116M |
|